No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human RBBP6 Antibodies:
anti-Mouse (Murine) RBBP6 Antibodies:
anti-Rat (Rattus) RBBP6 Antibodies:
Go to our pre-filtered search.
Human Polyclonal RBBP6 Primary Antibody for ICC, IF - ABIN4349510
Kishikawa, Otsuka, Yoshikawa, Ohno, Ijichi, Koike: Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1. in Nature communications 2016
Show all 2 Pubmed References
A crystal structure of the VP30-RBBP6 peptide complex revealed that RBBP6 mimics the viral nucleoprotein (NP) binding to the same interface of VP30.
RBBP6 might potentiate cervical carcinoma cell viability.
Results from a study on gene expression variability markers in early-stage human embryos shows that RBBP6 is a putative expression variability marker for the 3-day, 8-cell embryo stage.
RBBP6 overexpression could resist colorectal cancer cells against radiation.
These results suggest that the RBBP6-3 isoform may be involved in promoting apoptosis in cancerous cells.
RBBP6 is a candidate gene for myeloproliferative neoplasms (MPNs) susceptibility in a subset of pedigrees with familial MPN.
High expression levels of RBBP6 and high apoptosis levels were found in HIV-associated nephropathy (HIVAN) cases. This direct association between RBBP6 expression and apoptosis levels suggests that RBBP6 play a role in HIVAN pathogenesis.
gene silencing sensitises breast cancer cells to staurosporine and camptothecin-induced cell death
RBBP6 prevents DNA damage by destabilizing the transcriptional repressor ZBTB38.
RBBP6 gene variants are associated with glioma and contribute to glioma susceptibility
implicate RBBP6 and iso3 as novel regulators of 3' processing, especially of RNAs with AU-rich 3' UTRs.
these findings suggest that RBBP6 isoform 3 is a cell cycle regulator and may be deregulated in carcinogenesis
AGO2, PACT and TRBP are required for the efficient functioning of Dicer in cells
Taken together with the structural similarities to U-box-containing proteins, our data suggest that RBBP6 plays a role in chaperone-mediated ubiquitination and possibly in protein quality control.
RBBP6 may be involved in the degradation of p53, thereby enhancing cell proliferation and inhibiting apoptosis in lung cancer.
P2P-R expression may be translationally regulated by PUM2 and that P2P-R may modulate translation by influencing ribosomal protein gene expression
RBBP6 has a role in mRNA processing and ubiquitin-like pathways
The authors showed that RBBP6 and its isolated RING finger domain were able to ubiquitinate YB-1, resulting in its degradation in the proteosome. As a result, RBBP6 was able to suppress the levels of YB-1 in vivo and reduce its transactivational ability.
the PACT-p53 interaction plays a critical role in embryonic development and tumorigenesis and identify PACT as a member of negative regulators of p53.
Mapped six genes (EIF4G3, HSP90, RBBP6, IL8, TERT, and TERC) on the chromosomes of Equus caballus, Equus asinus, Equus grevyi, and Equus burchelli by fluorescence in situ hybridization.
The retinoblastoma tumor suppressor (pRB) protein binds with many other proteins. In various human cancers, pRB suppresses cellular proliferation and is inactivated. Cell cycle-dependent phosphorylation regulates the activity of pRB. This gene encodes a protein which binds to underphosphorylated but not phosphorylated pRB. Multiple alternatively spliced transcript variants that encode different isoforms have been found for this gene.
E3 ubiquitin-protein ligase RBBP6
, RB-binding Q-protein 1
, p53-associated cellular protein of testis
, proliferation potential-related protein
, protein P2P-R
, retinoblastoma-binding Q protein 1
, retinoblastoma-binding protein 6
, retinoblastoma binding protein 6
, retinoblastoma-binding protein 6-like